Publications
Peer-reviewed research articles and manuscripts in computational protein design
Peer-Reviewed Publications
Russell's viper venom: From diagnostic to bypassing agent for hemophilia?
2023VEIZAJ, D., et al.
Journal of Thrombosis and Haemostasis, 21(6), 1429–1431
View ArticleMinimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors
2024Schreuder, M., Jourdi, G., VEIZAJ, D., et al.
Journal of Thrombosis and Haemostasis, 22(8), 2211–2226
View ArticleModifications of the prothrombin active-site S4 subpocket confer resistance to dabigatran
2025Strijbis, V.J.F., Cheung, K.L., VEIZAJ, D., et al.
Thrombosis and Haemostasis (Preprint)
View ArticleMolecular biology and biochemistry of the coagulation factors and pathways of hemostasis
2025Bos, M.H.A., VEIZAJ, D., van 't Veer, C., & Reitsma, P.H.
In Williams Hematology, 11th ed. (Accepted)
Manuscripts in Preparation / Submitted
Expected 2026
In silico modeling of factor Xa–prothrombin complexes using AlphaFold-Multimer and molecular dynamics simulations for functional prediction
VEIZAJ, D., van Diest, R., Poole III, D.A., Cheung, K.L., Reitsma, P.H., Verhoef, D., Geerke, D.P., & Bos, M.H.A.
Computational characterization of factor Xa inhibition by rivaroxaban, apixaban, and edoxaban
VEIZAJ, D., Smiesko, M., & Bos, M.H.A.
Research Impact
My research contributions focus on computational protein engineering for therapeutic applications, particularly in the field of coagulation factors. The work has been published in leading journals in thrombosis and haemostasis, contributing to the development of bypassing agents for direct oral anticoagulants.
For a complete list of publications and citations, please refer to my CV or contact me directly.